Please login to the form below

Not currently logged in
Email:
Password:

ProStrakan

This page shows the latest ProStrakan news and features for those working in and with pharma, biotech and healthcare.

FDA approves Synergy's constipation drug Trulance

FDA approves Synergy's constipation drug Trulance

The latter indication is also targeted by AstraZeneca's Movantik (naloxegol), recently sold to ProStrakan in Europe where it is marketed as Moventig.

Latest news

  • AZ sells Zurampic rights to Gruenenthal for $230m AZ sells Zurampic rights to Gruenenthal for $230m

    In recent months the company has sold late-stage psoriasis candidate brodalumab to Valeant, transferred European rights to its opioid-induced constipation treatment Moventig (naloxegol) to ProStrakan and divested ex-US

  • AZ adds gout drug Zurampic to asset sale AZ adds gout drug Zurampic to asset sale

    Last month, AZ sold European rights to its opioid-induced constipation treatment Moventig (naloxegol) to ProStrakan and transferred Chinese rights to two elderly cardiovascular drugs - Plendil (felodipine) and Imdur (isosorbide mononitrate) -

  • AZ offloads more products in slimming drive AZ offloads more products in slimming drive

    Most recently, the pharma group sold European rights to its opioid-induced constipation treatment Moventig (naloxegol) to Scottish firm ProStrakan, a subsidiary of Japan's Kyowa Hakko Kirin, for an upfront

  • ProStrakan takeover moves a step closer

    ProStrakan takeover moves a step closer. Japanese conglomerate Kyowa Hakko Kirin has bought one share in ProStrakan, taking it a step closer to completing a takeover. ... Tokyo-based KHK is aiming to buy ProStrakan in a bid to grow its oncology drug

  • Survival strategy

    It will also be granted an exclusive licence to Prostrakan's products in emerging markets. ... 112. AstraZeneca/Daiichi Sankyo. Esomeprazole co-promotion Japan. Registration. 100. ProStrakan/Paladin. Refinancing strategic alliance.

More from news
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics